AGL 8.30 Increased By ▲ 0.44 (5.6%)
ANL 10.59 Increased By ▲ 0.24 (2.32%)
AVN 78.60 Increased By ▲ 0.70 (0.9%)
BOP 5.45 Increased By ▲ 0.06 (1.11%)
CNERGY 5.59 Increased By ▲ 0.58 (11.58%)
EFERT 80.25 Decreased By ▼ -0.55 (-0.68%)
EPCL 69.60 Increased By ▲ 1.50 (2.2%)
FCCL 15.30 Increased By ▲ 0.74 (5.08%)
FFL 6.53 Increased By ▲ 0.33 (5.32%)
FLYNG 7.18 Increased By ▲ 0.53 (7.97%)
GGGL 10.85 Increased By ▲ 0.27 (2.55%)
GGL 16.79 Increased By ▲ 0.38 (2.32%)
GTECH 8.14 Increased By ▲ 0.02 (0.25%)
HUMNL 7.04 Increased By ▲ 0.02 (0.28%)
KEL 2.99 Increased By ▲ 0.11 (3.82%)
LOTCHEM 30.77 Increased By ▲ 2.24 (7.85%)
MLCF 28.98 Increased By ▲ 2.03 (7.53%)
OGDC 82.75 Increased By ▲ 0.60 (0.73%)
PAEL 16.97 Increased By ▲ 0.32 (1.92%)
PIBTL 6.08 Increased By ▲ 0.24 (4.11%)
PRL 18.10 Increased By ▲ 1.35 (8.06%)
SILK 1.15 Increased By ▲ 0.05 (4.55%)
TELE 11.25 Increased By ▲ 0.28 (2.55%)
TPL 9.20 Decreased By ▼ -0.02 (-0.22%)
TPLP 19.88 Increased By ▲ 0.22 (1.12%)
TREET 26.46 Increased By ▲ 0.55 (2.12%)
TRG 94.60 Increased By ▲ 0.99 (1.06%)
UNITY 19.50 Increased By ▲ 0.50 (2.63%)
WAVES 14.34 Increased By ▲ 0.78 (5.75%)
WTL 1.30 Increased By ▲ 0.06 (4.84%)
BR100 4,187 Increased By 80.1 (1.95%)
BR30 15,474 Increased By 343.5 (2.27%)
KSE100 42,096 Increased By 670.9 (1.62%)
KSE30 15,883 Increased By 222.7 (1.42%)
World

Germany joins EU call for controls on vaccine exports

  • The European Union has so far authorised two vaccines -- the BioNTech/Pfizer and Moderna ones.
Published January 26, 2021

BERLIN: German Health Minister Jens Spahn on Tuesday joined EU calls for export controls on coronavirus vaccines amid discontent over a delay in rolling out pharmaceutical group AstraZeneca's jab to member countries.

Spahn said he was in favour of "vaccines leaving the EU needing a licence, so that we at least know what is being produced, what is leaving Europe -- and if it is leaving Europe, whether there is then a fair distribution".

Delays were understandable due to the complexity of the manufacturing process, he told the ZDF broadcaster, but they must "affect everyone fairly and equally".

Last Friday, British-Swedish company AstraZeneca said it would not meet its contractual delivery commitments to the European Union because of unexplained "reduced yields" in its European supply chain.

Europe's regulator EMA has not yet approved AstraZeneca's vaccine for general use in the bloc.

But the EMA is poised to add AstraZeneca's to the list of approved vaccines by the end of this week, on the understanding that it would be already on hand and available for immediate rollout.

The delivery delay warning by AstraZeneca came a week after US group Pfizer said it was also cutting early distribution volumes of its vaccine produced with German firm BioNTech.

Together, those announcements risk stalling EU vaccination programmes that depend on people getting two jabs weeks apart.

The bloc issued an angry warning to AstraZeneca on Monday, with EU Commissioner for health Stella Kyriakides saying the delay was "not acceptable to the European Union".

Kyriakides said Brussels would propose a "transparency mechanism" to track shipments of vaccine exported from the EU to non-member countries.

European Commission chief Ursula von der Leyen pledged a week ago to inoculate 70 percent of adults in the EU by the end of August.

The European Union has so far authorised two vaccines -- the BioNTech/Pfizer and Moderna ones.

Comments

Comments are closed.